Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3. - Wikidata - awgldk - TriplyDB

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

http://www.wikidata.org/entity/Q33385643

about

Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkers Diagnostic utility of galectin-3 in thyroid cancer.(99m)Tc-labeled-rhTSH analogue (TR1401) for imaging poorly differentiated metastatic thyroid cancer.Hemithyroidectomy is the preferred initial operative approach for an indeterminate fine needle aspiration biopsy diagnosis.Galectin-3 regulates p21 stability in human prostate cancer cells.Galectin-3 Performance in Histologic a Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis.Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.Recent Development of Nuclear Molecular Imaging in Thyroid Cancer.Galectin-3 detection on large-needle aspiration biopsy improves preoperative selection of thyroid nodules: A prospective cohort study Galectins in Cancer and Translational Medicine: From Bench to Bedside

P2860

Q21134996-FF748383-66ED-4131-B018-49CB736B4D70 Q33816239-12106020-886A-4FDE-B510-AE4E831FDEB2 Q33931440-456D023B-0BF7-4060-9519-21718A991F34 Q35998832-E8E79F5A-77CA-4FF8-B7CD-9ADA24C66423 Q37542482-0561968B-A3BB-4851-BE52-14858BD0C497 Q38628967-FD0EE407-DBF0-47AA-8007-D411FA356BD8 Q47696912-7212F4A1-208A-4A56-8B6B-2731E00C7867 Q48159180-45B40149-2F9E-4257-9469-8F3EEC31F251 Q55413120-C08215F4-633D-4043-93A5-3F3A8CA61924 Q58186884-1FF9D3FB-8C78-42EC-8A92-C9FA4E3CFA15 Q59133822-85807AA5-754E-4616-B3D0-950DCD1EF0D9

P2860

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

http://www.wikidata.org/entity/Q33385643

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

@ast

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

@en

type

label

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

@ast

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

@en

prefLabel

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

@ast

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

@en

P1433

Q33385643-D736AF45-7801-403A-BA58-DC8070613940

P1476

Q33385643-79D3BF52-BB7B-4049-9022-BA5EF02F2F50

P2093

Q33385643-1C25D265-BC00-45F6-BACA-64619F945132

Q33385643-259B5D7D-723B-40F0-8609-188649CCE357

Q33385643-67EC3D0A-974D-4435-9955-D2F6E7655C29

Q33385643-6CECA4A0-98C7-4DC7-9084-D898F48EDDB1

Q33385643-72B1038E-D182-43EC-90DB-9D2A818FB407

Q33385643-80F6BD0E-74C6-47DD-A4E0-42FE8CFDCB8C

Q33385643-8252E1F7-F2F9-4C56-81E9-C26DDA61F403

P2860

Q33385643-08361916-707B-4F12-9736-51DBFF215D14

Q33385643-092F715C-6B60-4EF2-8741-20D37B41F803

Q33385643-14DF6539-5270-4E07-B8A5-D8E74C48435D

Q33385643-257E4FEC-8B75-4BE6-A111-35D6CD250B68

Q33385643-2B0F2168-AB1F-4CBE-9236-FB115D2F3876

Q33385643-3D2ADCAF-E020-439E-B1B6-4497A57E2C79

Q33385643-48F906AD-DC79-4177-8A74-26E20B7CCAD9

Q33385643-4FCC8707-38B6-4608-934A-9218F97E574E

Q33385643-51C2D98D-9418-4E3A-9268-A6AD10DC6A6C

Q33385643-6C547195-F879-47CF-802C-52294BFABF87

P304

Q33385643-16521C94-24C2-4E90-8B6A-EC6505A40060

P31

Q33385643-3BEB36C6-3D42-4011-A32C-A5AA306FB75B

P356

Q33385643-DDE326CF-D3D6-40FE-BA51-9A90B36AEC30

P407

Q33385643-AB568AD7-B245-41BB-91CA-46908AB71ACC

P433

Q33385643-949A7DC5-F6E7-4D0B-8C66-1B8EE8DA09BF

P478

Q33385643-8919E805-C013-4E3E-84B1-1BC1B804A230

P50

Q33385643-06627967-8B54-4CB8-A758-F2EA31F8E6A9

Q33385643-54A5350F-BCB2-4774-ACE8-2A8B86CABDAC

Q33385643-64187369-60F5-49C1-97B9-4C0552B3C823

Q33385643-C09F3545-EDBE-499F-8A2F-50C154A09CDE

Q33385643-EB2AB6BC-D4ED-449C-9379-3D2790B08920

P577

Q33385643-B47D3B96-8DBF-45E8-B473-CCB7E01D8C20

P5875

Q33385643-C7C4ADC1-5D00-430B-8EFA-4205DCF92FA2

P698

Q33385643-E92B452C-3890-41C8-A891-0B4E1D1D6377

P921

Q33385643-F425A4F2-0448-4C69-A86F-6C5AECEC7F2A

P932

Q33385643-653E9662-9501-41D5-974B-1D2222173B4A

P356

JOURNAL.PONE.0003768

P1433

P1476

Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.

@en

P2093

Alberto Signore

http://www.w3.org/2001/XMLSchema#string

Calogero D'Alessandria

http://www.w3.org/2001/XMLSchema#string

Carlo Trotta

http://www.w3.org/2001/XMLSchema#string

Fabrizio Del Prete

http://www.w3.org/2001/XMLSchema#string

Luca Lavra

http://www.w3.org/2001/XMLSchema#string

Maria Gemma Parisella

http://www.w3.org/2001/XMLSchema#string

Sten Braesch-Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential

Reduction-mediated technetium-99m labeling of monoclonal antibodies.

Galectins as modulators of tumour progression.

Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells.

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.

Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia.

Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology.

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells.

P304

e3768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0003768

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Scopinaro

Armando Bartolazzi

Roberto Massari

Alessandro Soluri

P577

2008-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23484707

http://www.w3.org/2001/XMLSchema#string

P698

19020658

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2582451

http://www.w3.org/2001/XMLSchema#string